We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
We are proud to announce that our 2019 Corporate Responsibility Report has been published and is now live on the West website. In its fourth year, West’s 2019 Corporate Responsibility Report provides insight into West’s initiatives in Environmental Sustainability, as well as five other impact pillars – Health and Safety; Quality; Compliance and Ethics; Diversity and Talent; and Philanthropy.
Corporate Responsibility (CR) has been part of West’s DNA throughout our more than 95-year history. We are guided by our mission to contain and deliver injectable therapies to our customers and the patients we jointly serve across the globe. Delivering on this mission using sustainable business practices is critical and has been a long-standing imperative at West. We embrace this responsibility and strive to be good stewards in all our business decisions—from the raw materials we use, to our production and manufacturing techniques, to how we package and distribute our products.
After outperforming our prior five-year goal targets well ahead of schedule, in 2019 we established a new set of five-year goals, and we are proud of our progress. In 2019, we were recognized for the great strides we have made in our CR Program by several influential organizations, including Newsweek and Investor’s Business Daily.
In 2019, our One West Team made impressive contributions to our CR Program, and helped us to reach these milestones:
Please read the full 2019 Corporate Responsibility Report here. In upcoming blogs, we will take a closer look at the six different focus areas of West’s CR Program.
West is proud to announce that we have published our 2021 Corporate Responsibility (CR) Report, Purpose. Driven., which is now available on <a href="/about-west/corporate-responsibility">West’s website.</a> <br />This is West’s 6<sup>th</sup> annual CR Report, and highlights ESG successes from over the past year, including progress on environmental sustainability goals, diversity and inclusion, and success around the Company’s philanthropic efforts. The publication also highlights some of the recognition received for our ESG (Environmental, Social, Governance) performance, including placement in Barron’s Top 100 Most Sustainable Companies, Corporate Social Responsibility Programme of the Year from Pharma Industry Awards in Ireland, and a Silver Stevie Award for Corporate Social Responsibility.
Philanthropy is a cornerstone of West’s culture. It anchors our purpose of standing by the side of our customers to help make a difference in our global community.
West believes that, as a global organization, we have a duty and obligation to contribute to a sustainable future and that each of us, working together, can make a difference. While we know that sound environmental practices make good business sense, the underlying reasons behind our commitment are the many benefits these practices provide to our communities, now and for future generations. As a company with the mission to improve patient health, it stands to reason that we are equally committed to a sustained investment in creating a healthier environment.
West recognizes its responsibility to operate with integrity and to proactively identify potential misconduct. We hold ourselves accountable to the highest standards of quality, integrity and respect for our team members, our shareholders, our customers, and the patients we jointly serve.
At West, we actively foster an inclusive and collaborative culture for our team members where different views and perspectives are welcomed and valued. We are convinced that this approach brings forth innovation, learning and growth for our team members on a global basis.
English
Chinese
